期刊文献+

温病血分证病机及治法探析 被引量:11

Discuss on the Pathogenesis and Treatment Principle of Xuefen Syndrome in Warm Diseases
下载PDF
导出
摘要 探讨了温病血分证的病机、分期及治法,提出温病血分证宜分三期辨治,初期血热耗血,瘀热交结,治宜凉血散血;中期为血热妄行,兼有瘀滞,治宜凉血解毒、散血止血;后期为热瘀气脱或气随血脱,治疗重在扶正固脱。 The paper discussed the pathogenesis,staging and treatment method of xuefen syndrome in warm diseases.At the initial stage,the pathogenesis was impairment of blood induced by blood heat,as well as combination of stasis and heat,so the treatment principle should be cooling blood and dissipating stasis.When it came to the mid-term,it turned into bleeding due to blood-heat combined with stasis and should be treated with cooling blood and dissipating stasis to stop bleeding.As for the later period,it was qi prostration due to heat and stasis or excessive bleeding followed by exhaustion of vital energy and the treatment aimed to strengthen body resistance and relieving desertion.
作者 魏凯峰 杨进 WEI Kai-feng;YANG Jin(School of Chinese Medicine,School of Integrated Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing,210023,China)
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2021年第1期13-15,共3页 Journal of Nanjing University of Traditional Chinese Medicine
基金 国家自然科学基金青年基金(81001489) 江苏高校优势学科建设工程 全国老中医药专家学术经验继承工作项目 南京中医药大学中医学院·中西医结合学院教学改革研究开放课题。
关键词 温病学 三期辨治 血分证 the science of warm disease treatment bases on three stages xuefen syndrome
  • 相关文献

参考文献3

二级参考文献12

  • 1刘敏涓,刘泽霖.脓毒症与DIC的新见解[J].血栓与止血学,2006,12(1):27-29. 被引量:4
  • 2孟江.温病学[M].上海:上海科学技术出版社,1985.17.
  • 3[2]LEVI M,de JONGE E,van der POLL T.Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation[J].Crit Care Med,2001,29:S90-94.
  • 4[3]LEVI M,de JONGE E,van der POLL T.New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology[J].Ann Med,2004,36:41-49.
  • 5[4]KINASEWITZ GT,ZEIN JG,LEE GL,Nazir SA,Taylor FB Jr.Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis[J].Crit Care Med,2005,33(10):2214-2221.
  • 6[5]TAYLOR FB Jr,TOH CH,HOOTS WK,et al.Towards definition,clinical and laboratory criteria,and a scoring system for disseminated intravascular coagulation[J].Thromb Haemost,2001,86:1327-1330.
  • 7[6]HAMBLETON J,LEUNG LL,LEVI M.Coagulation:consultative hemostasis[J].Hematology (Am Soc Hematol Educ Program),2002,335-352.
  • 8[7]BICK RL.Disseninated intravascular coagulation current concepts of etiology,pathophysiology,diagnosis and treatment[J].Hematol Oncol Clin North Am,2003,17:149-176.
  • 9[8]WARREN BL,EID A,SINGER P,et al.High dose antithrombin Ⅲ in severe sepsis:a randomized controlled trial[J].JAMA,2001,286:1869-1878.
  • 10[9]WATANABE R,WADA H,SAKAKURA M,et al.Plasma levels of activated protein C-protein C inhibitor complex patients with hypercoagulable states[J].Am J Hematol,2000,65(1):35-40.

共引文献21

同被引文献166

引证文献11

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部